Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations

• Giovanni Brandi ,

  * E-mail: giovanni.brandi@unibo.it

  Affiliations “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy, “G. Prodi” Interdepartmental Center for Cancer Research (C.I.R.C.), University of Bologna, Bologna, Italy

  ⨯
• Simona Tavolari,

  Affiliations “G. Prodi” Interdepartmental Center for Cancer Research (C.I.R.C.), University of Bologna, Bologna, Italy, Center for Applied Biomedical Research (C.R.B.A.), Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Francesco De Rosa,

  Affiliation “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Stefania Di Girolamo,

  Affiliation “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Valentina Agostini,

  Affiliation “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Maria Aurelia Barbera,

  Affiliation “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Giorgio Frega,

  Affiliation “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

  ⨯
• Guido Biasco

  Affiliations “L. and A. Seràgnoli” Department of Hematology and Oncological Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy, “G. Prodi” Interdepartmental Center for Cancer Research (C.I.R.C.), University of Bologna, Bologna, Italy

  ⨯